SynthesisApplied health economics and health policy2024

Evolving Evidence-Based Value Assessment of One-Time Therapies: Tisagenlecleucel as a Case Study.

Theodore Laetsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.